Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.45 USD | +0.83% | -5.33% | -21.14% |
Apr. 23 | Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission | MT |
Apr. 22 | Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.14% | 8.56B | |
-0.49% | 103B | |
+3.31% | 96.73B | |
+1.66% | 21.31B | |
-16.16% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-22.87% | 13.68B | |
+6.32% | 13.44B | |
+21.46% | 10.98B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Morgan Stanley Adjusts Legend Biotech Price Target to $55 From $51, Maintains Overweight Rating